News
SonderMind said the purchase will help providers deliver personalized mental healthcare.
The company plans to use the funding to expand into new regions. It aims to operate nationwide by 2023.
The deal is expected to close by the end of 2021.
This news comes roughly a year after the company signed a $500 million deal with Boehringer Ingelheim.
Also, new guidance published on classification of medical devices in the EU.
The modules are based on the group's minimum clinical standards for osteoporosis care.
Also, a Māori public health organisation develops a new tool to bring timely COVID-19-related information to Māori people.
The new acquisition is set to help Everly Health grow its women's health offerings.
Zerigo Health, formerly Clarify Medical, makes a connected phototherapy device for skin conditions like psoriasis, vitiligo and eczema.
The tool uses virtual reality to modify media content in order to help children boost their visual acuity.